Skip to main content
Erschienen in: Inflammation 1/2014

01.02.2014

Effects of OX40–OX40L Interaction on the Nuclear Factor of Activated T Cells c1 in ApoE-Deficient Mice

verfasst von: Jin-chuan Yan, Liang-jie Xu, Cui-ping Wang, Zhong-qun Wang

Erschienen in: Inflammation | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

We previously reported the emerging role of OX40–OX40L interaction in inflammation and atherosclerosis. However, the mechanism by which OX40–OX40L interaction contributes to pathogenesis is poorly understood. This study investigated the effects of OX40–OX40L interaction on the nuclear factor of activated T cells c1 (NFATc1) in ApoE−/− mice. Atherosclerotic plaque was induced via rapid perivascular carotid collar placement in ApoE−/− mice. The expression levels of OX40, OX40L, and NFATc1 in the lymphocytes were measured via real-time polymerase chain reaction and flow cytometry. The presence of NFATc1 in the atherosclerotic plaque was detected via immunohistochemistry, and the level of IL-4 was measured via enzyme-linked immunosorbent assay. The expression level of NFATc1 significantly increased in atherosclerotic lesion and in the leukocytes from the ApoE−/− mice. After stimulating OX40–OX40L interaction, the mRNA and protein expression levels of NFATc1 in the lymphocytes significantly increased. Meanwhile, anti-OX40LmAb significantly suppressed the expression of NFATc1 in the leukocytes and substantially elevated the level of IL-4. NFATc1 inhibitor markedly suppressed IL-4 production. This study suggests that OX40–OX40L interaction regulates the expression of NFATc1, which may play a critical role in atherosclerotic plaque formation, and may therefore have implications with pathophysiology of atherosclerosis.
Literatur
1.
Zurück zum Zitat Gotsman, I., A.H. Sharpe, and A.H. Lichtman. 2008. T-cell costimulation and coinhibition in atherosclerosis. Circ Res 103: 1220–1231.CrossRef Gotsman, I., A.H. Sharpe, and A.H. Lichtman. 2008. T-cell costimulation and coinhibition in atherosclerosis. Circ Res 103: 1220–1231.CrossRef
2.
Zurück zum Zitat Van Wanrooij, E.J., G.H. van Puijvelde, P. de Vos, H. Yagita, T.J. van Berkel, and J. Kuiper. 2007. Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 27: 204–210.CrossRef Van Wanrooij, E.J., G.H. van Puijvelde, P. de Vos, H. Yagita, T.J. van Berkel, and J. Kuiper. 2007. Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 27: 204–210.CrossRef
3.
Zurück zum Zitat Hogan, P.G., L. Chen, J. Nardone, and A. Rao. 2003. Transcriptional regulation by calcium calcineurin, and NFAT. Genes Dev 17: 2205–2232.CrossRef Hogan, P.G., L. Chen, J. Nardone, and A. Rao. 2003. Transcriptional regulation by calcium calcineurin, and NFAT. Genes Dev 17: 2205–2232.CrossRef
4.
Zurück zum Zitat Macian, F. 2005. NFAT proteins: Key regulators of T-cell development and function. Nat Rev Immunol 5: 472–484.CrossRef Macian, F. 2005. NFAT proteins: Key regulators of T-cell development and function. Nat Rev Immunol 5: 472–484.CrossRef
5.
Zurück zum Zitat Macian, F., C. Garcia-Rodriguez, and A. Rao. 2000. Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun. EMBO J 19: 4783–4795.CrossRef Macian, F., C. Garcia-Rodriguez, and A. Rao. 2000. Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun. EMBO J 19: 4783–4795.CrossRef
6.
Zurück zum Zitat de la Pompa, J.L., L.A. Timmerman, H. Takimoto, H. Yoshida, A.J. Elia, E. Samper, J. Potter, A. Wakeham, L. Marengere, B.L. Langille, G.R. Crabtree, and T.W. Mak. 1998. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392: 182–186.CrossRef de la Pompa, J.L., L.A. Timmerman, H. Takimoto, H. Yoshida, A.J. Elia, E. Samper, J. Potter, A. Wakeham, L. Marengere, B.L. Langille, G.R. Crabtree, and T.W. Mak. 1998. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392: 182–186.CrossRef
7.
Zurück zum Zitat Ranger, A.M., M.J. Grusby, M.R. Hodge, E.M. Gravallese, F.C. de la Brousse, T. Hoey, C. Mickanin, H.S. Baldwin, and L.H. Glimcher. 1998. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392: 186–190.CrossRef Ranger, A.M., M.J. Grusby, M.R. Hodge, E.M. Gravallese, F.C. de la Brousse, T. Hoey, C. Mickanin, H.S. Baldwin, and L.H. Glimcher. 1998. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392: 186–190.CrossRef
8.
Zurück zum Zitat Sieber, M., and R. Baumgrass. 2009. Novel inhibitors of the calcineurin/NFATc hub—Alternatives to CsA and FK506. Cell Commun Signal 7: 25.CrossRef Sieber, M., and R. Baumgrass. 2009. Novel inhibitors of the calcineurin/NFATc hub—Alternatives to CsA and FK506. Cell Commun Signal 7: 25.CrossRef
9.
Zurück zum Zitat Karpurapu, M., D. Wang, N.K. Singh, Q. Li, and G.N. Rao. 2008. NFATc1 targets cyclin A in the regulation of vascular smooth muscle cell multiplication during restenosis. J Biol Chem 283: 26577–26590.CrossRef Karpurapu, M., D. Wang, N.K. Singh, Q. Li, and G.N. Rao. 2008. NFATc1 targets cyclin A in the regulation of vascular smooth muscle cell multiplication during restenosis. J Biol Chem 283: 26577–26590.CrossRef
10.
Zurück zum Zitat Croft, M. 2003. Co-stimulatory members of the TNFR family: Keys to effective T-cell immunity? Nat Rev Immuno 3: 609–620.CrossRef Croft, M. 2003. Co-stimulatory members of the TNFR family: Keys to effective T-cell immunity? Nat Rev Immuno 3: 609–620.CrossRef
11.
Zurück zum Zitat Watts, T.H. 2005. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 23: 23–68.CrossRef Watts, T.H. 2005. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 23: 23–68.CrossRef
12.
Zurück zum Zitat Sugamura, K., N. Ishii, and A.D. Weinberg. 2004. Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40. Nat Rev Immunol 4: 420–431.CrossRef Sugamura, K., N. Ishii, and A.D. Weinberg. 2004. Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40. Nat Rev Immunol 4: 420–431.CrossRef
13.
Zurück zum Zitat Monticelli, S., and A. Rao. 2002. NFAT1 and NFAT2 are positive regulators of IL-4 gene transcription. Eur J Immunol 32: 2971–2978.CrossRef Monticelli, S., and A. Rao. 2002. NFAT1 and NFAT2 are positive regulators of IL-4 gene transcription. Eur J Immunol 32: 2971–2978.CrossRef
14.
Zurück zum Zitat Liu, D.M., J.C. Yan, C.P. Wang, G.H. Chen, S. Ding, P.J. Liu, and R.Z. Du. 2008. The clinical implications of increased OX40 ligand expression in patients with acute coronary syndrome. Clin Chim Acta 397: 22–26.CrossRef Liu, D.M., J.C. Yan, C.P. Wang, G.H. Chen, S. Ding, P.J. Liu, and R.Z. Du. 2008. The clinical implications of increased OX40 ligand expression in patients with acute coronary syndrome. Clin Chim Acta 397: 22–26.CrossRef
15.
Zurück zum Zitat von der Thusen, J.H., T.J. van Berkel, and E.A. Biessen. 2001. Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Circulation 103: 1164–1170.CrossRef von der Thusen, J.H., T.J. van Berkel, and E.A. Biessen. 2001. Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Circulation 103: 1164–1170.CrossRef
16.
Zurück zum Zitat Takeda, I., S. Ine, N. Killeen, L.C. Ndhlovu, K. Murata, S. Satomi, K. Sugamura, and N. Ishii. 2004. Distinct roles for the OX40–OX40 ligand interaction in regulatory and nonregulatory T cells. J Immunol 172: 3580–3589.CrossRef Takeda, I., S. Ine, N. Killeen, L.C. Ndhlovu, K. Murata, S. Satomi, K. Sugamura, and N. Ishii. 2004. Distinct roles for the OX40–OX40 ligand interaction in regulatory and nonregulatory T cells. J Immunol 172: 3580–3589.CrossRef
17.
Zurück zum Zitat Peng, D.Q., S. Huang, S.G. Yuan, and S.P. Zhao. 2010. Increased soluble OX40L is associated with carotid intima-media thickness. Clin Lab 56: 449–457.PubMed Peng, D.Q., S. Huang, S.G. Yuan, and S.P. Zhao. 2010. Increased soluble OX40L is associated with carotid intima-media thickness. Clin Lab 56: 449–457.PubMed
18.
Zurück zum Zitat Nakano, M., Y. Fukumoto, K. Satoh, Y. Ito, Y. Kagaya, N. Ishii, K. Sugamura, and H. Shimokawa. 2010. OX40 ligand plays an important role in the development of atherosclerosis through vasa vasorum neovascularization. Cardiovasc Res 88: 539–546.CrossRef Nakano, M., Y. Fukumoto, K. Satoh, Y. Ito, Y. Kagaya, N. Ishii, K. Sugamura, and H. Shimokawa. 2010. OX40 ligand plays an important role in the development of atherosclerosis through vasa vasorum neovascularization. Cardiovasc Res 88: 539–546.CrossRef
19.
Zurück zum Zitat Yan, J., C. Wang, R. Du, P. Liu, and G. Chen. 2009. OX40–OX40L ligand interaction may activate phospholipase C signal transduction pathway in human umbilical vein endothelial cells. Chem Biol Interact 180: 460–464.CrossRef Yan, J., C. Wang, R. Du, P. Liu, and G. Chen. 2009. OX40–OX40L ligand interaction may activate phospholipase C signal transduction pathway in human umbilical vein endothelial cells. Chem Biol Interact 180: 460–464.CrossRef
20.
Zurück zum Zitat Kim, M.S., and Y.M. Usachev. 2009. Mitochondrial Ca2+ cycling facilitates activation of the transcription factor NFAT in sensory neurons. J Neurosci 29: 12101–12114.CrossRef Kim, M.S., and Y.M. Usachev. 2009. Mitochondrial Ca2+ cycling facilitates activation of the transcription factor NFAT in sensory neurons. J Neurosci 29: 12101–12114.CrossRef
Metadaten
Titel
Effects of OX40–OX40L Interaction on the Nuclear Factor of Activated T Cells c1 in ApoE-Deficient Mice
verfasst von
Jin-chuan Yan
Liang-jie Xu
Cui-ping Wang
Zhong-qun Wang
Publikationsdatum
01.02.2014
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 1/2014
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-013-9731-y

Weitere Artikel der Ausgabe 1/2014

Inflammation 1/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.